Merçè Brunet

6.2k total citations · 1 hit paper
144 papers, 3.6k citations indexed

About

Merçè Brunet is a scholar working on Transplantation, Surgery and Infectious Diseases. According to data from OpenAlex, Merçè Brunet has authored 144 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Transplantation, 38 papers in Surgery and 20 papers in Infectious Diseases. Recurrent topics in Merçè Brunet's work include Renal Transplantation Outcomes and Treatments (69 papers), Organ Transplantation Techniques and Outcomes (25 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Merçè Brunet is often cited by papers focused on Renal Transplantation Outcomes and Treatments (69 papers), Organ Transplantation Techniques and Outcomes (25 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Merçè Brunet collaborates with scholars based in Spain, France and United States. Merçè Brunet's co-authors include Olga Millán, Jordi Bruix, Marta Burrel, María Isabel Real, Josep M. Llovet, María Sala, Carmen Ayuso, Xavier Montañá, Lluı́s Castells and Marı́a Varela and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Science of The Total Environment.

In The Last Decade

Merçè Brunet

137 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics

2006 707 citations Merçè Brunet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Merçè Brunet Spain	32	1.5k	832	814	634	583	144	3.6k
Shigeru Satoh Japan	36	1.2k 0.8×	806 1.0×	120 0.1×	306 0.5×	826 1.4×	294	5.1k
Alexandre Hertig France	38	686 0.5×	733 0.9×	110 0.1×	637 1.0×	580 1.0×	170	4.2k
Charles W. Putnam United States	35	557 0.4×	1.8k 2.1×	1.1k 1.3×	632 1.0×	180 0.3×	120	4.5k
Guy H. Neild United Kingdom	35	301 0.2×	518 0.6×	112 0.1×	405 0.6×	477 0.8×	123	4.1k
J S Cameron United Kingdom	47	544 0.4×	570 0.7×	317 0.4×	332 0.5×	283 0.5×	187	6.9k
Joshua D. Mezrich United States	28	666 0.4×	1.4k 1.7×	744 0.9×	320 0.5×	57 0.1×	69	3.9k
Konrad S. Famulski Canada	39	3.2k 2.1×	2.1k 2.5×	174 0.2×	650 1.0×	112 0.2×	87	5.4k
Rodney S. Markin United States	30	181 0.1×	911 1.1×	469 0.6×	741 1.2×	167 0.3×	101	2.9k
Can Li China	29	355 0.2×	598 0.7×	102 0.1×	271 0.4×	151 0.3×	122	2.9k
Eberhard L. Renner Canada	38	354 0.2×	2.0k 2.4×	2.8k 3.4×	1.9k 3.1×	127 0.2×	160	4.5k

Countries citing papers authored by Merçè Brunet

Since Specialization

Citations

This map shows the geographic impact of Merçè Brunet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merçè Brunet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merçè Brunet more than expected).

Fields of papers citing papers by Merçè Brunet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merçè Brunet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merçè Brunet. The network helps show where Merçè Brunet may publish in the future.

Co-authorship network of co-authors of Merçè Brunet

This figure shows the co-authorship network connecting the top 25 collaborators of Merçè Brunet. A scholar is included among the top collaborators of Merçè Brunet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merçè Brunet. Merçè Brunet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hernáez, Mikel, et al.. (2025). Pharmacogenetic Influences on Individual Responses to Ocular Hypotensive Agents in Glaucoma Patients. Pharmaceutics. 17(3). 325–325.

Julian, J.A., María Queralt Salas, Gisela Riu-Viladoms, et al.. (2024). Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation. Pharmaceuticals. 17(5). 553–553. 1 indexed citations

Rigo‐Bonnin, Raül, et al.. (2024). Calculation of reference intervals for the concentrations of α-tocopherol and retinol in serum using indirect data-mining procedures. Clinica Chimica Acta. 561. 119822–119822. 1 indexed citations

Brunet, Merçè, et al.. (2023). Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactions. SHILAP Revista de lepidopterología. 4(4). 341–352. 4 indexed citations

Brunet, Merçè, et al.. (2023). Influencia de la farmacogenética en la diversidad de respuesta a las estatinas asociada a las reacciones adversas. SHILAP Revista de lepidopterología. 4(4). 353–364.

Bádenas, Célia, Constantino Fondevila, Wladimiro Jiménez, et al.. (2021). Monitoring of Donor‐Derived Cell‐Free DNA by Short Tandem Repeats: Concentration of Total Cell‐Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation. Liver Transplantation. 28(2). 257–268. 26 indexed citations

Hernández‐Tejero, María, Fátima Aziz, Cristina Espinosa, et al.. (2020). Meropenem population pharmacokinetics in patients with decompensated cirrhosis and severe infections. Journal of Antimicrobial Chemotherapy. 75(12). 3619–3624. 11 indexed citations

Gómez‐Bravo, Miguel Ángel, María Apellániz-Ruiz, Magdalena Salcedo, et al.. (2017). Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients. Pharmacogenetics and Genomics. 28(2). 41–48. 14 indexed citations

Brunet, Merçè, et al.. (2016). L'art de convertir le fer forgé en acier et l'art d'adoucir le fer fondu ou De faire des ouvrages de fer fondu aussi finis que de fer forgé. Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya).

10.

Vouillarmet, Julien, Fanny Buron, C. Houzard, et al.. (2013). The First Simultaneous Kidney–Adrenal Gland–Pancreas Transplantation: Outcome at 1 Year. American Journal of Transplantation. 13(7). 1905–1909. 7 indexed citations

11.

Gómez‐Bravo, Miguel Ángel, Magdalena Salcedo, Constantino Fondevila, et al.. (2013). Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. The Journal of Clinical Pharmacology. 53(11). 1146–1154. 26 indexed citations

12.

Miró, José M., Frederic Cofán, Joan Carles Trullàs, et al.. (2012). Renal Dysfunction in the Setting of HIV/AIDS. Current HIV/AIDS Reports. 9(3). 187–199. 21 indexed citations

13.

Brandhorst, Gunnar, Michael Oellerich, Merçè Brunet, et al.. (2011). Individually Tailored Immunosuppression: Is There a Role for Biomarkers?. Clinical Chemistry. 57(3). 376–381. 2 indexed citations

14.

Sánchez‐Fueyo, Alberto, et al.. (2011). How Long Should Initiation of Calcineurin Inhibitors Be Delayed to Protect Renal Function in Liver Transplantation?. Transplantation Proceedings. 43(3). 697–698. 4 indexed citations

15.

Codas, R., Fabrice Danjou, William Hanf, et al.. (2009). Renal graft mass and transplant outcome. Transplant International. 22. 184–184. 1 indexed citations

16.

Wallemacq, Pierre, Victor W. Armstrong, Merçè Brunet, et al.. (2009). Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference. Therapeutic Drug Monitoring. 31(2). 139–152. 362 indexed citations

17.

Grinyó, Josep M., Henrik Ekberg, Federico Oppenheimer, et al.. (2007). Pharmacokinetics of total and free mycophenolic acid in renal transplantation receiving standard-dose cyclosporine, low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: The symphony PK sub-study. Transplant International. 20. 177–177. 4 indexed citations

18.

Vernotte, J., et al.. (2000). Modelization and Extrapolation of Time Deviation of USO and Atomic Clocks in GNSS-2 Context. Defense Technical Information Center (DTIC). 1 indexed citations

19.

Brunet, Merçè, Roser Velasco, M. Torra, et al.. (1995). 59 COMPARATIVE ANALYSIS OF TACROLIMUS IN WHOLE BLOOD BY PRO-TRAC(tm) ELISA AND MEIA IMX METHODS. Therapeutic Drug Monitoring. 17(4). 398–398. 1 indexed citations

20.

Castellano, M. A., et al.. (1992). Organochlorine residues in human adipose tissue of the population of Zaragoza (Spain). Bulletin of Environmental Contamination and Toxicology. 48(4). 561–6. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact